GlassScriptPhysician profile
Jeffrey V Deluca
NPI 1487653226
$1,518.78
in general payments reported to CMS, 2019-2025
9 companies · $225 in 2025
The $225 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $830 · 2020: $28.63 · 2021: $26.18 · 2022: $196 · 2023: $160 · 2024: $53.12 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $437.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $718.97 | 2019-2024 | Evos |
| Polaris Technology Solutions LLC | $261.20 | 2023-2025 | |
| Stryker Corporation | $198.04 | 2022-2025 | Triathlon, Pangea |
| Depuy Synthes Sales INC. | $140.02 | 2019 | |
| Novo Nordisk INC | $105.46 | 2022-2024 | Rybelsus, Ozempic |
| Vericel Corporation | $31.69 | 2021-2022 | |
| Djo, LLC | $28.63 | 2020 | |
| Cerapedics INC. | $23.43 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Bioventus LLC | $11.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Deluca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.